Medical researcher dedicated to developing immunotherapies for the treatment of cancer - with a focus on brain cancers and melanoma
Adelaide, Australia
Joined March 2012
- Tweets27
- Following81
- Followers110
- Likes49
Lisa Ebert retweeted
Every 3–4 months, we meet with Consumer Advocates—cancer survivors and bereaved families—to share research and clinical trial updates and seek their feedback. We’re grateful for their invaluable insights and support.
Lisa Ebert retweeted
A quick rewind to one of our lab’s yearly traditions! 🧬 We had a fantastic time at the ASI SA–NT Branch Meeting 2026 in Victor Harbor, learning from fellow students and inspiring keynote speakers, while celebrating our lab members who presented their research! 🔬✨
Lisa Ebert retweeted
Several members of our lab attended ISCT ANZ 2026 at the Melbourne Convention & Exhibition Centre, where global experts shared advances in cell and gene therapy, regenerative medicine and immunotherapy. Congratulations to Dr. Katie Williams on winning the Best Poster Award!
Lisa Ebert retweeted
A team effort today to showcase @UniversitySA's new tissue culture facility that will help advance research into childhood #braincancer & #AML. Kudos to @CCB_Research scientists Prof Richard D'Andrea, Assoc Prof @lisamebert & @CopsforKidsorg for funding it brnw.ch/21wQQFs
We are recruiting! Come join us in Adelaide to work on cutting-edge translational research and contribute to developing CAR-T cell therapies for brain tumours. Two post-doc positions available, closing soon, details at careers.pageuppeople.com/532…
Lisa Ebert retweeted
Our study, "EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses" was published. I thank @leesa_lerts, & Dr Ryan Cross, w Melinda, Stacie, Sarah, @lisamebert @dralexdav @drendersby @auscancadoc & Prof Kate D A 🧵
Fabulous to see our CAR-T cell clinical trial published in JITC today! These positive safety results are now supporting our current trials in glioma patients
New #JITC article: Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers bit.ly/3ykeCnV @lisamebert
Lisa Ebert retweeted
New #JITC article: Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers bit.ly/3ykeCnV @lisamebert
Lisa Ebert retweeted
Congratulations to our Translational Oncology Lab, who have just won the Premier’s Excellence Award for Driving Innovation!
Excited to be part of a team selected as finalist for the SA Science Excellence & Innovation Awards! #SAScienceAwards Recognising our work done at @CCB_Research @RoyalAdelHosp to develop new targeted treatments for cancer.
Lisa Ebert retweeted
"Nobody else was in the least bit interested... Well, if you try going to a symposium today on tumor immunology, you can’t get in the room."
Reflections on tumour immunology in Australia with @khanna_rajiv, Prof Delia Nelson & Prof Ian Frazer
bit.ly/48g5lKQ
So excited to be a part of this new clinical trial for patients with brain cancer, building on our pre-clinical work at @CCB_Research and supported by @NeuroSurgRF , @hosp_research
An exciting new recurrent #glioblastoma clinical trial, KARPOS, has recently launched in South Australia. To register for this trial, please follow: anzctr.org.au/Trial/Registra…
All trial enquiries can be directed to: [email protected]
ALT Clinical Trial Alert: KARPOS "KARPOS is a phase I trial led by Prof Michael Brown at the Royal Adelaide Hospital, involving custom manufacture of a cancer-targeting cellular therapy from each patient’s own blood cells. Based on recent results, we believe this provides a new approach for treating recurrent glioblastoma although safety is the trial’s main objective. Patients need to stay in Adelaide at least 4 weeks." Dr Lisa ebert Foundation Member - ABCARA
Lisa Ebert retweeted
The month of May is Brain Cancer Awareness Month, also known as Grey May.
The UniSA Centre for Cancer Biology (CCB) is a research centre dedicated to cancer research. Discover more about the research undertaken at CCB fal.cn/3y2Hm @CCB_Research
This one has been a long time coming together, so I'm really excited to have it up as a preprint now! We're loving FAP as a CAR-T cell target, and the bystander killing aspect is super interesting ... stay tuned for more!
This Post is from an account that no longer exists. Learn more
Very happy to be a part of this exciting work with a wonderful team!
Excited, relieved and thankful to advance the fundamental biology that underpins aggressive melanoma and pancreatic cancer together with @NicoVoelcker @sgeorgebarreto My Mahoney and our exceptional AIs @DrMarinaPajic @TMEM_Samuel Ruth Ganss @lisamebert @LGMartelotto Michael Brown
Lisa Ebert retweeted
Adelaide Immunology representing at #ASI2022MEL what a fun SIG to be involved with 😂 Let’s make it an annual thing! Give us a retweet if you’re an Adelaide immunology researcher and tell us what you’re working on..
#TcellsForLife @iMOD_lab @ASImmunology
We're hiring! Looking for a talented Research Officer in cancer immunotherapy to join our team in the Translational Oncology lab at @CCB_Research. Job ad available at careers.pageuppeople.com/532…
